Home Newsfeeds Morgan Stanley Maintains Overweight on PACCAR

Morgan Stanley Maintains Overweight on PACCAR

Morgan Stanley analyst Dillon Cumming maintains PACCAR (NASDAQ:PCAR) with a Overweight.

byBenzinga Newsdesk

February 8, 2023

1 minute read

Morgan Stanley analyst Dillon Cumming maintains PACCAR (NASDAQ:PCAR) with a Overweight.

Nvidia’s New Blackwell GPUs Expected To Boost Future Revenues, Analyst Forecasts

By Anusuya Lahiri

May 15, 3:00 PM

KeyBanc analyst maintains Overweight rating on Nvidia (NVDA) with $1,200 price target. Anticipates strong demand and revenue growth in data center sector.

NVDA

News

Helios Technologies’ Balboa Water Group Signs Agreement Providing Balboa With An Exclusive License To Integrate WaterGuru Technology Into Balboa’s Leading Products For The Spa Industry

By Benzinga Newsdesk

May 7, 5:22 PM

Helios Technologies, Inc. (NYSE:HLIO), a global leader in highly engineered motion control and electronic controls technology, is excited to announce that its operating company Balboa Water Group ("Balboa") has signed a

HLIO

Silvergate Capital Shares Plummet Over 45% After Massive Customer Withdrawals

By Murtuza Merchant

January 5, 12:11 PM

Shares of crypto-focused bank Silvergate Capital Corp (NYSE: SI) plummeted by more than 47% on Thursday, after the bank released preliminary fourth-quarter results that showed a significan

$FTT

Analyst Ratings

4 Analysts Have This to Say About OrthoPediatrics

By Benzinga Insights

September 1, 11:00 AM

OrthoPediatrics (NASDAQ:KIDS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

KIDS

Morgan Stanley Maintains Overweight on PACCAR

Related Posts

Nvidia’s New Blackwell GPUs Expected To Boost Future Revenues, Analyst Forecasts

Helios Technologies’ Balboa Water Group Signs Agreement Providing Balboa With An Exclusive License To Integrate WaterGuru Technology Into Balboa’s Leading Products For The Spa Industry

Silvergate Capital Shares Plummet Over 45% After Massive Customer Withdrawals

4 Analysts Have This to Say About OrthoPediatrics